JNJ-4929821

CAS No. 836671-12-6

JNJ-4929821( JNJ4929821 )

Catalog No. M16099 CAS No. 836671-12-6

JNJ-4929821 is a potent, reversible methionine aminopeptidase-2 (MetAP-2) inhibitor with IC50 of 8 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JNJ-4929821
  • Note
    Research use only, not for human use.
  • Brief Description
    JNJ-4929821 is a potent, reversible methionine aminopeptidase-2 (MetAP-2) inhibitor with IC50 of 8 nM.
  • Description
    JNJ-4929821 is a potent, reversible methionine aminopeptidase-2 (MetAP-2) inhibitor with IC50 of 8 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    JNJ4929821
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Aminopeptidase
  • Recptor
    Aminopeptidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    836671-12-6
  • Formula Weight
    352.402
  • Molecular Formula
    C14H13FN4O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(C1=CC=CS1)(N(CC2=NN=CN2)CC3=CC=C(F)C=C3)=O
  • Chemical Name
    N-((4H-1,2,4-triazol-3-yl)methyl)-N-(4-fluorobenzyl)thiophene-2-sulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Heinrich T, et al. Bioorg Med Chem Lett. 2017 Feb 1;27(3):551-556. 2. Garrabrant T, et al. Angiogenesis. 2004;7(2):91-6.
molnova catalog
related products
  • Bestatin hydrochlori...

    Bestatin (Ubenimex) hydrochlorideis an inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.

  • Firibastat

    QGC-001 is a glutamyl aminopeptidase antagonist and an orally active brain penetrating prodrug of EC33. It is a first-in-class brain aminopeptidase A (APA) inhibitor with a Ki of 200 nM.

  • TNP-470

    TNP-470 (AGM-1470) is a specific, rreversible MetAP-2 inhibitor and and annti-angiogenic compound.